InvestorsHub Logo
Followers 264
Posts 877
Boards Moderated 0
Alias Born 03/05/2007

Re: None

Sunday, 08/09/2020 11:14:39 PM

Sunday, August 09, 2020 11:14:39 PM

Post# of 44690
Aviptadil is the Mother of All Drugs (MOAD)

Aviptadil is the Mother of All Medicines (MOAM) in case medicine is cleaner word than drug.

RLFTF is the mother of All Stocks (MOAS).

Let me explain,

1. We are in the world pandemic of COVID-19 which the live people have never experienced before. Every country, every person (maybe babies excluded) on the planet needs this drug. RLF-100 is fast-tracked for moderate to severe COVID-19 patients to prevent progression to respiratory failure. But from the fact that RLF-100 blocks virus replication and prevent the synthesis of cytokines, we can safely say that this drug can be used as a prophylactic drug. So every one could use this drug and everyone want to have this drug, just like sanitizers and masks. Every government in the world wants to stockpile this drug. Right now there is nothing more important than the cure drug for COVID-19 in the whole world.

2. So far we only see the report of dramatic response of RLF-100 on 6 patients from one site. There are trials at multiple sites. The data from multiple sites prompted FDA grant the fast track. The approval is just a matter of time.

3. The active pharmaceutical ingredient API vasoactive intestine peptide VIP is a naturally occurring peptide of 28 amino acids. It has been studied and used for many indications for decades. Its safety profile is well-documented and it is considered to be safe. Comparing to the rushed and politicized vaccines, I would rather take this drug instead of vaccines. Many people might think the same way.

4. There are several other candidates in the forms of small molecules or monoclonal antibodies in various stages of clinical trials and approval, which are familiar to the investment community, but nothing comparable to this one in terms of efficacy and advancement of trials and approval. Some of them might get approved. They can be used in junction with RLF-100 to achieve better and broader benefits.

5. Relief Therapeutics has to work with raw material manufacturers, pharmaceutical manufacturers, distributors to make and deliver the drug to patients, hospitals and organizations. Luckily the pharmaceutical world has hammered out the protocols and networks to work together and share the responsibility and profit. My only concern is the manufacturing of the 28 amino acid peptide. To synthesize and produce thousands of tons of synthetic peptide in very short period of time will be a daunting task.

6. Now lets throw politics into the mix. The US presidential election comes in three months. If Donald Trump dumps millions even billions into this company and its collaborators and claims he saves the US and the world, I will not be surprised.

7. If you had gained from or missed the OW*CP run during the MJ mania, you should know that RLFTF run will be much much bigger than that and will be sustained for long time. The impact and shock wave will be the memory of life time. If you missed the opportunity of investing in bitcoin or Amazon at its infancy, here is your chance to gain that kind of profit in RLFTF. The only difference is you can make that kind of money in months not in years.

8. In summary, as the proverb says, in crisis there is opportunity. The opportunity is now and is it RLFTF.